BioSpace News Archive

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, announced that it will present clinical electroencephalogram data, including in Alzheimer’s patients, from the Phase 1 a/b trial of its lead development candidate, ATH-1017, at the upcoming Alzheimer’s Association International Conference 2021.

OncXerna Therapeutics, Inc., a precision medicine company using an innovative RNA-expression based biomarker platform to predict patient responses to its first-in-class targeted oncology therapies, announced that Laura Benjamin, Ph.D., Founder and CEO of OncXerna, will present at the LifeSci Partners Private Company Summer Symposium taking place virtually from July 21-23, 2021.

Clinical Laserthermia Systems AB, developer of high precision, image-guided focal laser ablation systems, announced that a review article titled “Local Destruction of Tumors and Systemic Immune Effects” has been published in the Journal “Frontiers in Oncology” by the company’s co-founder and Senior Clinical Advisor, Professor Karl-Göran Tranberg.

PHILADELPHIA, July 19, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants, today announced the appointment of Elizabeth (Beth) White, Ph.D., as chief business officer and senior vice president of operations. “Beth is a proven industry professional who possesses a unique blend of business,

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced the appointment of Carolyn E. Taylor to its Board of Directors, effective as of July 16, 2021.

Pluristem Therapeutics Inc., a leading biotechnology company, announced the Board of Director appointments of Prof. Varda Shalev, a physician, medical researcher, and Professor of Medicine at the Tel Aviv University’s School of Public Health, and Mr. Doron Birger, a high-tech industry executive with a background in bringing groundbreaking products to market.

Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced receipt of FDA approval of its Senza® System for the treatment of chronic pain associated with Painful Diabetic Neuropathy.

SINOVAC Biotech Ltd., a leading provider of biopharmaceutical products in China, announced it received a drug registration approval from the National Medical Product Administration of China for its Sabin strain based inactivated polio vaccine on July 12, 2021.

Kadmon Holdings, Inc. announced that data from the pivotal ROCKstar clinical trial of REZUROCK™ for the treatment of chronic graft-versus-host disease were published in the journal Blood.

BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (Nasdaq: BTAI), today announced that Dr. Vimal Mehta, Ph.D., Founder and Chief Executive Officer of BioXcel, will participate in the Canaccord Genuity 41st Annual Growth Conference on Thursday, August 12, 2021 at 9:30 a.m. Eastern Time.